Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
… (rego) in patients (pts) with metastatic colorectal cancer (mCRC) in the CodeBreaK 300 study. Taieb J, Fakih MG, …
Can We Trust Health Care Stated-Preference Studies Conducted on Mobile Devices? Share on: March 23, 2021 What do rapidly changing technologies mean to the collection of stated-preference studies – studies that ask individuals what they value in their …
… if your patient has to choose between a highly effective drug with a bad side effect profile and a less effective drug with minimal side effects, which would they choose? …
… Medicare Drug Price Negotiation Under the Inflation Reduction Act … Act (IRA) was signed into law in 2022 and includes the Drug Price Negotiation (DPN) program, which will allow … We’ll also explore what is new on the horizon for Round 2 drug negotiations. Related Services Market Access and …
… to successfully implement PRO measurement within the drug development program to generate data to support … to negotiate regulatory, reimbursement, and market access drug development hurdles. Judging PRO instrument quality and …
… Atopic dermatitis Dry skin Eczema Herpes Psoriasis Skin cancer Basal cell carcinoma Squamous cell carcinoma Melanoma … models (cost effectiveness, budget impact) Drug utilization studies Economic burden of illness studies …
… models (cost effectiveness, budget impact) Drug utilization studies Economic burden of illness studies …
… SGO 2023 Annual Meeting on Women's Cancer Share on: Saturday, March 25 - Tuesday, March 28, … be presented at the SGO 2023 Annual Meeting on Women's Cancer. Real-world evaluation of PARP inhibitor tolerability in advanced ovarian cancer – retrospective US cohort study. Simmons DJ, Blank …
… research on a broad range of health problems which include cancer, cardiovascular disease, neurologic disease, birth defects, injuries, environmental exposures, and adverse effects of pharmaceutical agents. Some specific … or coauthored more than 450 peer-reviewed scholarly publications. He is a former president of the Society for …
… Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation.” … be considered when evaluating PROs intended to support drug submissions as well as medical devices. The draft offers … related to the development, evaluation, and regulatory review of clinical outcome assessments and states that its …